Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Earnings

Review historical estimates and see whether a company has beaten or missed expectations.

FOXO

FOXO Technologies Inc

Jun 14 • 04:00PM ET

0.2890

Dollar change +0.0501
Percentage change 20.97	%

Healthcare • Health Information Services • USA • AMEX

Stock Detail • Compare Perf. • Financials • Options Chain • Save to Portfolio • Create Alert

Scroll to Statements

Index	-	P/E	-	EPS (ttm)	-5.16	Insider Own	60.88%	Shs Outstand	7.65M	Perf Week	12.67%
Market Cap	3.08M	Forward P/E	-	EPS next Y	-	Insider Trans	-7.15%	Shs Float	4.17M	Perf Month	-0.34%
Income	-29.83M	PEG	-	EPS next Q	-	Inst Own	3.51%	Short Float	5.00%	Perf Quarter	-9.69%
Sales	0.38M	P/S	8.11	EPS this Y	-	Inst Trans	-81.10%	Short Ratio	0.17	Perf Half Y	-0.31%
Book/sh	-1.84	P/B	-	EPS next Y	-	ROA	-301.26%	Short Interest	0.21M	Perf Year	-90.71%
Cash/sh	-	P/C	-	EPS next 5Y	-	ROE	-1754.50%	52W Range	0.22 - 5.28	Perf YTD	-9.60%
Dividend Est.	-	P/FCF	-	EPS past 5Y	-	ROI	-	52W High	-94.52%	Beta	2.03
Dividend TTM	-	Quick Ratio	-	Sales past 5Y	-1111.63%	Gross Margin	-	52W Low	31.36%	ATR (14)	0.06
Dividend Ex-Date	-	Current Ratio	0.02	EPS Y/Y TTM	87.09%	Oper. Margin	-5098.94%	RSI (14)	49.15	Volatility	19.51% 20.47%
Employees	5	Debt/Eq	-	Sales Y/Y TTM	-618.36%	Profit Margin	-7891.27%	Recom	-	Target Price	-
Option/Short	No / No	LT Debt/Eq	-	EPS Q/Q	6.25%	Payout	-	Rel Volume	39.25	Prev Close	0.24
Sales Surprise	-	EPS Surprise	-	Sales Q/Q	-93.16%	Earnings	-	Avg Volume	1.26M	Price	0.29
SMA20	-5.76%	SMA50	-2.54%	SMA200	-44.71%	Trades		Volume	49,471,599	Change	20.97%

Jun-14-24 05:30PM	FOXO Technologies Inc. Announces Receipt of Notice of Non-Compliance with NYSE Continued Listing Requirements; Completes Steps it Believes are Required to Regain Compliance (GlobeNewswire) +20.97%
08:30AM	FOXO Technologies Enters into Share Exchange Agreements to Acquire Healthcare Operations from Rennova Health, Inc. (GlobeNewswire)
Apr-23-24 05:00PM	FOXO Technologies Inc. Announces Receipt of Notice of Non-Compliance with NYSE Continued Listing Requirements (GlobeNewswire)
Feb-14-24 09:32AM	FOXO Technologies Announces Non-Binding Agreement for Potentially Transformative Merger with M2i Global (GlobeNewswire) -8.50%
Jan-25-24 05:00PM	FOXO Technologies Announces Appointment of Capital Markets Veteran Francis Colt deWolf to the Board of Directors (Business Wire)
08:30AM	Loading…
Jan-22-24 08:30AM	FOXO Technologies Formalizes License Agreement with KR8.ai to Power New Epigenetic Wellness Solutions (Business Wire) -14.49%
Dec-19-23 08:30AM	FOXO Technologies Inc. Announces Receipt of Notice of Non-Compliance with NYSE Continued Listing Requirements (Business Wire)
Dec-01-23 09:01AM	FOXO Technologies On Track to Commence Commercial Rollout of VITHAR AI Health Coach in Early 2024 (Business Wire) +22.82%
Nov-29-23 04:30PM	FOXO Technologies Receives Notice from NYSE American Regarding Late Filing of Quarterly Report on Form 10-Q (Business Wire) -5.49%
Nov-10-23 08:30AM	FOXO Technologies Provides Reminder for Webinar to be Held Today, November 10th at 10 AM Eastern Time, to Unveil VITHAR AI Health Coach (Business Wire)
Nov-08-23 09:00AM	FOXO Technologies to Unveil VITHAR AI Health Coach; Schedules Webinar for Friday, November 10th at 10 AM Eastern Time (Business Wire) -21.89%
Nov-07-23 09:23AM	FOXO Technologies Expects Class A Common Stock to Resume Trading, Today, November 7, in Connection with 1-for-10 Reverse Stock Split (Business Wire) -17.53%
Oct-30-23 08:30AM	FOXO Technologies Unveils Plans for New Direct-to Consumer Offering Combining the Companys Epigenetic Data with the Power of AI (Business Wire) -24.80%
Oct-27-23 05:15PM	FOXO Technologies Inc. Announces Reverse Stock Split (Business Wire) -6.99%
Oct-23-23 08:00AM	FOXO Technologies Completes Strategic Alternatives Review and Outlines Latest Progress Executing Corporate Strategy (Business Wire)
08:00AM	Loading…
Oct-13-23 08:00AM	FOXO Technologies Announces Issue Notification from USPTO for a Patent Leveraging Machine Learning Approaches to Enable the Commercialization of Epigenetic Biomarkers (Business Wire) +8.47%
Oct-06-23 08:30AM	FOXO Technologies Interim CEO Mark White Provides Letter to Shareholders Outlining New AI-Enabled Direct-to-Consumer Strategy and Immediate Expense Reductions (Business Wire) +17.20%
Sep-06-23 08:30AM	FOXO Technologies Announces Agreement With Atrio Insurance (Business Wire) +14.48%
Aug-31-23 08:30AM	FOXO Technologies Inc. Announces NYSE American Acceptance of Compliance Plan (Business Wire) +7.97%
Aug-18-23 04:15PM	FOXO Technologies Inc. Announces Receipt of Second Notice of Non-Compliance from NYSE American (Business Wire)
Aug-17-23 08:30AM	FOXO Technologies Collaborates with DataRobot to Pave the Way for AI-Driven Epigenetic Biomarker Research in Human Longevity (Business Wire)
Aug-10-23 04:05PM	FOXO Technologies Announces Second Quarter 2023 Financial Results (Business Wire)
Aug-08-23 08:30AM	FOXO Technologies Sets Second Quarter 2023 Business Update Call for Thursday, August 10, 2023 at 3:15 p.m. CT (Business Wire) -9.77%
Aug-07-23 08:30AM	Longevity Biotech Companies GERO and FOXO Technologies to Embark on Joint Initiative on Artificial Intelligence and Epigenetic Data to Discover Signatures of Human Health Trajectories (Business Wire) -7.98%
Jul-19-23 08:00AM	FOXO Technologies Launches Bioinformatics Services to Revolutionize Epigenetic Data Analysis (Business Wire) +19.07%
Jun-16-23 05:30AM	FOXO Technologies Inc. Announces Receipt of Notice of Non-Compliance with NYSE Continued Listing Requirements (Business Wire) -5.02%
May-30-23 05:09PM	FOXO Technologies Announces Results of Annual Stockholders Meeting (Business Wire) +14.60%
May-17-23 04:30PM	NYSE American Has Commenced Delisting Proceedings in the FOXO WS warrants of FOXO Technologies Inc. (Business Wire)
May-11-23 04:15PM	FOXO Technologies Announces First Quarter 2023 Financial Results (Business Wire)
Apr-18-23 08:00AM	FOXO Technologies Announces Resignation of Taylor Fay, Chief Operating Officer (Business Wire) -8.08%
08:00AM	Loading…
08:00AM	FOXO Technologies Announces Direct-to-Consumer Launch of Longevity Report Beta Product (Business Wire)
Mar-30-23 04:05PM	FOXO Technologies Announces Full Year 2022 Financial Results and Recent Business Highlights (Business Wire)
Mar-22-23 07:00PM	FOXO Technologies Inc. Sets Fourth Quarter and Full Year 2022 Business Update Call for Thursday, March 30, 2023 at 3:15 p.m. CT (Business Wire)
Dec-08-22 04:15PM	FOXO LIFE to Begin Distribution Relationship with AmSuisse to Sell Life Insurance Designed to Keep You Alive (Business Wire)
Nov-23-22 06:30PM	FOXO Technologies Announces Filing of Form 10-Q for the Third Quarter 2022 (Business Wire) -13.33%
Nov-15-22 12:57PM	FOXO Technologies Announces Management Changes and Delays Filing of Form 10-Q (Business Wire) -12.85%
01:24AM	FOXO Technologies Announces Departure of Chief Product Officer, Erin Sharoni (Business Wire)
Nov-14-22 04:31PM	FOXO Technologies Postpones Third Quarter 2022 Earnings Report and Conference Call (Business Wire) +6.64%
08:00AM	FOXO Technologies Announces Agreement With Haven Life (Business Wire)
Nov-07-22 04:01PM	FOXO Technologies Inc. Sets Third Quarter 2022 Earnings Call for Monday, November 14, 2022 at 3:15 p.m. CT (Business Wire)
Oct-12-22 08:00AM	FOXO Technologies Announces First Distribution Partner and Begins Product Rollout in California; Expands Executive Team With Insurance Industry Talent (Business Wire) +59.30%

FOXO Technologies, Inc. develops genetic sequencing technology, artificial intelligence and bioinformatics tools. It operates through the FOXO Labs and FOXO Life segments. The FOXO Labs segment refers to the research and development and is commercializing proprietary epigenetic biomarker technology. The FOXO Life segment is involved in combining life insurance with a dynamic molecular health and wellness platform. The company was founded in 2020 and is headquartered in Minneapolis, MN.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
WHITE MARK BRIAN	Interim CEO	Feb 06 '24	Sale	0.42	250,000	105,000	0	Feb 07 03:07 PM
WARD MARTIN CHRISTOPHER	Interim CFO	Feb 06 '24	Sale	0.42	250,000	105,000	0	Feb 07 03:07 PM
Dowling Vincent J. Jr	10% Owner	Jul 14 '23	Sale	0.16	3,000	491	4,647,405	Jul 18 03:06 PM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

FOXO

FOXO Technologies Inc

Upgrade your FINVIZ experience